Researchers at Monash University have announced the latest COVID19 breakthrough, a drug used to Treat Head Lice.
4 April 2020 | AtoZMarkets CoronaVirus news – While the whole world is in lockdown Monah University researchers in Melbourne Australia have shared their latest Coronavirus breakthrough. According to the announcement an anti-parasite drug against head lice has killed off the Covid19 cells within two days. The name of this drug is Ivermectin.
Ivermectin is widely available throughout the world. Doctors use Ivermectin to treat HIV, influenza, Zika Virus, Head lice infection and now possibly COVID19 treatment too. Tests have been so far conducted in a lab environment where the widely available drug killed the virus cells within 48 hours.
Monash University Biomedicine Discovery Institute’s Dr. Kylie Wagstaff commented the following:
“We found that even a single dose could essentially remove all viral RNA (effectively remove all genetic materials of COVID19) by 48 hours and that even at 24 hours there was really significant reduction in it.
Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective – that’s the next step, in times when we’re having a global pandemic and there isn’t an approved treatment, if we had a compound that was already available around the world then that might help people sooner. Realistically it’s going to be a while before a vaccine is broadly available.”
It is worth noting that the breakthrough announcement does not mean that human testing has been done. In order to see this method used in the medical world pre-clinical testing and clinical trials need to be conducted.
Is Ivermectin Covid19 treatment medicine?
Ivermectin is not primarily designed for COVID19 (Coronavirus) treatment. It is, however, an FDA-approved anti-parasitic drug. Ivermectin has also shown to be effective in vitro against viruses including HIV, dengue and influenza.
Ivermectin Coronavirus tests have been conducted jointly by Monash Biomedicine Discovery Institute and the Peter Doherty Institute of Infection and Immunity.
The study findings have been published in Antiviral Research.
On behalf of the AtoZMarkets.com team, we would like to share our in-depth gratitude for those of doctors, medical staff, shop keepers, sanitizers and everyone else risking their lives to save ours. #STAYHOME #SaveLives